Iovance Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.66-$5.63 |
Market Cap | $1.9B |
Shares Short | 106M |
Financials
See moreRevenue (12 Mos) | $285.6M |
Revenue Growth (YoY) | 44.8% |
Gross Profit (12 Mos) | $112.6M |
Diluted EPS | -$0.92 |
News
See moreYahoo Finance • 10 days ago
Iovance Biotherapeutics to Present at Upcoming Conference
Yahoo Finance • last month
Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy Now?
Yahoo Finance • last month
Iovance Biotherapeutics Inc (IOVA): Jefferies Draws Attention Amtagvi Drug
Yahoo Finance • last month
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 975 |